scholarly article | Q13442814 |
P356 | DOI | 10.1002/ART.1780380914 |
P698 | PubMed publication ID | 7575721 |
P50 | author | Susan Manzi | Q111603941 |
Rosalind Ramsey-Goldman | Q67485111 | ||
P2093 | author name string | Medsger TA Jr | |
McCarty DJ | |||
LaPorte RE | |||
Kwoh CK | |||
P433 | issue | 9 | |
P921 | main subject | systemic lupus erythematosus | Q1485 |
P304 | page(s) | 1260-1270 | |
P577 | publication date | 1995-09-01 | |
P1433 | published in | Arthritis & Rheumatology | Q4797636 |
P1476 | title | Incidence of systemic lupus erythematosus. Race and gender differences | |
P478 | volume | 38 |
Q55317432 | 13-year-old Girl with Fevers. |
Q50984066 | 17β-Estradiol (E-2) administration to male (NZB × SWR)F₁ mice results in increased Id(LN)F₁-reactive memory T-lymphocytes and accelerated glomerulonephritis. |
Q37294365 | 46,X,del(X)(q13) Turner's syndrome women with systemic lupus erythematosus in a pedigree multiplex for SLE. |
Q34153866 | A major susceptibility locus for systemic lupus erythemathosus maps to chromosome 1q31 |
Q35579663 | A prospective study of lupus and rheumatoid arthritis in relation to deployment in support of iraq and afghanistan: the millennium cohort study |
Q36925450 | A role for Fli-1 in B cell proliferation: implications for SLE pathogenesis |
Q38842399 | A study of the influence of ethnicity on serology and clinical features in lupus |
Q64102174 | Analyses of Skin and Peripheral Blood Transcriptional Data in Cutaneous Lupus Reveals CCR2-A Novel Potential Therapeutic Target |
Q43850415 | Antiphospholipid (Hughes') syndrome in African-Americans: IgA aCL and abeta2 glycoprotein-I is the most frequent isotype |
Q53079370 | Assessment of clinical manifestations, disease activity and organ damage in 996 Korean patients with systemic lupus erythematosus: comparison with other Asian populations. |
Q57332153 | Association between baseline levels of C-reactive protein (CRP) and a dinucleotide repeat polymorphism in the intron of the CRP gene |
Q45342887 | Association of common single-nucleotide polymorphisms in innate immune genes with differences in TLR-induced cytokine production in neonates. |
Q33392397 | Association of increased serum IL-33 levels with clinical and laboratory characteristics of systemic lupus erythematosus in Chinese population |
Q33640302 | Autoimmune blistering diseases in females: a review |
Q57055880 | Autoimmune vertigo: an update on vestibular disorders associated with autoimmune mechanisms |
Q28082493 | Biomarkers for CNS involvement in pediatric lupus |
Q30715531 | Burden of systemic lupus erythematosus on employment and work productivity: data from a large cohort in the southeastern United States |
Q38237868 | Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus |
Q37312560 | Characteristics related to early secondary amenorrhoea and pregnancy among women diagnosed with systemic lupus erythematosus: an analysis using the GOAL study. |
Q88559342 | Cigarette smoking and the pathogenesis of systemic lupus erythematosus |
Q38994352 | Clinical characteristics and laboratory findings of 252 Chinese patients with anti-phospholipid syndrome: comparison with Euro-Phospholipid cohort |
Q37299358 | Comparison of the systemic lupus erythematosus activity questionnaire and the systemic lupus erythematosus disease activity index in a black barbadian population |
Q34607079 | Copy Number Variation of TLR-7 Gene and its Association with the Development of Systemic Lupus Erythematosus in Female Patients from Yucatan Mexico. |
Q33697263 | Cross-sectional analysis of a collaborative Web-based database for lupus erythematosus-associated skin lesions: prospective enrollment of 114 patients |
Q34466996 | Cutaneous Connective Tissue Diseases: Epidemiology, Diagnosis, and Treatment |
Q38731631 | Cutaneous Lupus Erythematosus: An Update on Pathogenesis, Diagnosis and Treatment |
Q36632600 | Cutaneous lupus erythematosus: understanding of clinical features, genetic basis, and pathobiology of disease guides therapeutic strategies |
Q55409997 | Defining biological subsets in systemic lupus erythematosus: progress toward personalized therapy. |
Q46810854 | Defining the role of mycophenolate mofetil in the treatment of proliferative lupus nephritis. |
Q24243533 | Dehydroepiandrosterone for systemic lupus erythematosus |
Q24245412 | Dehydroepiandrosterone for systemic lupus erythematosus |
Q33342337 | Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States. |
Q37173453 | Differences in subclinical cardiovascular disease between African American and Caucasian women with systemic lupus erythematosus |
Q24616851 | Different disparities of gender and race among the thrombotic thrombocytopenic purpura and hemolytic-uremic syndromes |
Q29417056 | Differential genetic associations for systemic lupus erythematosus based on anti-dsDNA autoantibody production |
Q37413878 | Disparities in lupus care and outcomes |
Q44369790 | Disparities in renal replacement in lupus nephritis: current practice and future implications |
Q35547605 | Donor CD8 T cells and IFN-gamma are critical for sex-based differences in donor CD4 T cell engraftment and lupus-like phenotype in short-term chronic graft-versus-host disease mice |
Q35051164 | ESRD from lupus nephritis in the United States, 1995-2010 |
Q39392025 | Effective Self-Management Interventions for Patients With Lupus: Potential Impact of Peer Mentoring |
Q28385351 | Environmental exposures and the development of systemic lupus erythematosus |
Q37069392 | Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004 |
Q22299248 | Epidemiology and socioeconomic impact of skin disease in lupus erythematosus |
Q35567251 | Epidemiology of systemic lupus erythematosus and cutaneous lupus erythematosus in a predominantly white population in the United States |
Q47329844 | Epidemiology of systemic lupus erythematosus in a northern Spanish population: gender and age influence on immunological features |
Q53839415 | Epidemiology of systemic lupus erythematosus. |
Q22255575 | Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden |
Q40065685 | Epidemiology of systemic lupus erythematosus: capturing the butterfly. |
Q39560849 | Estimating the incidence of systemic lupus erythematosus in a tropical region (Natal, Brazil). |
Q33568785 | Estradiol, but not testosterone, heightens cortisol-mediated negative feedback on pulsatile ACTH secretion and ACTH approximate entropy in unstressed older men and women |
Q37698320 | Estrogen and autoimmune disease |
Q36676984 | Ethnic and geographical differences in systemic lupus erythematosus: an overview |
Q58735957 | Evidence of a distinct group of Black African patients with systemic lupus erythematosus |
Q36527339 | Expression of TLR-7, MyD88, NF-kB, and INF-α in B Lymphocytes of Mayan Women with Systemic Lupus Erythematosus in Mexico |
Q34824708 | Factors that determine body composition of female systemic lupus erythematosus (SLE) patients in Sri Lanka: a comparative study using dual-energy x-ray absorptiometry |
Q52411167 | Familial autoimmunity as a risk factor for systemic lupus erythematosus and vice versa: a case-control study. |
Q38061970 | Focus on systemic lupus erythematosus in indigenous Australians: towards a better understanding of autoimmune diseases |
Q30577177 | Frequency of fractures in women with systemic lupus erythematosus: comparison with United States population data |
Q35606947 | Gender differences in collagen diseases |
Q33834884 | Gender differences in depression and antidepressant pharmacokinetics and adverse events |
Q36181968 | Gender differences in stress response: Role of developmental and biological determinants |
Q37030621 | General aspects of the genetics of SLE. |
Q44822518 | Genetic imprinting of autoantibody repertoires in systemic lupus erythematosus patients |
Q36921228 | Geographical Clustering of Juvenile Onset Systemic Lupus Erythematosus within the Sultanate of Oman. |
Q46234526 | Geographical variation in mortality from systemic lupus erythematosus in the United States |
Q59324987 | HIV and systemic lupus erythematosus: the clinical and diagnostic dilemmas of having dual diagnosis |
Q35626210 | Hair and scalp disorders in ethnic populations |
Q24246699 | Herbal medicines for systemic lupus erythematosus |
Q51191137 | High incidence and prevalence of systemic lupus erythematosus in Norway. |
Q36320468 | High sensitivity, specificity and predictive value of the Connective Tissue Disease Screening Questionnaire among urban African-American women |
Q43505242 | Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study |
Q36678195 | Hypothalamic-pituitary-adrenal axis response to acute psychosocial stress: Effects of biological sex and circulating sex hormones |
Q21136392 | Identification of unique microRNA signature associated with lupus nephritis |
Q37096392 | Immune mechanism: a 'double-edged sword'. |
Q36360777 | Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian-European populations |
Q30248879 | Impact of sex disparities on the clinical manifestations in patients with systemic lupus erythematosus: A systematic review and meta-analysis |
Q46603420 | Incidence and prevalence of adult systemic lupus erythematosus in a large US managed-care population |
Q34424638 | Incidence and prevalence of lupus in Buenos Aires, Argentina: a 11-year health management organisation-based study |
Q62050411 | Incidence and prevalence of systemic lupus erythematosus among Arab and Chaldean Americans in southeastern Michigan: the Michigan Lupus Epidemiology and Surveillance Program |
Q36422028 | Incidence and prevalence of systemic lupus erythematosus in a district of north Italy. |
Q37636312 | Incidence of cutaneous lupus erythematosus, 1965-2005: a population-based study |
Q30384836 | Incidental retinal vascular occlusions on hydroxychloroquine screening in patients with systemic lupus erythematosus. |
Q50115176 | Individuals living with lupus: findings from the LUPUS UK Members Survey 2014. |
Q36313012 | Influence of ethnicity on childhood-onset systemic lupus erythematosus: results from a multiethnic multicenter Canadian cohort |
Q35774938 | Interactions between worm infections and malaria |
Q36093309 | Intervention to Improve Quality of life for African-AmericaN lupus patients (IQAN): study protocol for a randomized controlled trial of a unique a la carte intervention approach to self-management of lupus in African Americans |
Q54289079 | Laminin-1 (LM-111) in preeclampsia and systemic lupus erythematosus. |
Q51148648 | Nationwide population-based epidemiologic study of systemic lupus erythematosus in Taiwan. |
Q40396348 | Pattern of systemic lupus erythematosus among Nigerians |
Q33723511 | Pediatric lupus--are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus? |
Q36260045 | Peer Support and Psychosocial Pain Management Strategies for Children with Systemic Lupus Erythematosus |
Q46651738 | Peripheral blood antigen-presenting cells from African-Americans exhibit increased CD80 and CD86 expression. |
Q35596715 | Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus |
Q39363927 | Physician-patient interactions and outcomes in systemic lupus erythematosus (SLE): a conceptual model |
Q34343779 | Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program |
Q94366942 | Predictors of non-response and non-compliance in African American lupus patients: Findings from the Balancing Lupus Experiences with Stress Strategies (BLESS) Study |
Q37777642 | Prevalence and burden of pediatric-onset systemic lupus erythematosus |
Q35899088 | Prevalence and sociodemographic correlates of antinuclear antibodies in the United States |
Q37391150 | Prevalence of mood and anxiety disorders in women with systemic lupus erythematosus |
Q33819611 | Prevalence of systemic lupus erythematosus in South Korea: an administrative database study |
Q48636445 | Race/Ethnicity and Cardiovascular Events Among Patients With Systemic Lupus Erythematosus |
Q28383077 | Racial Disparities in the Prevalence of Arthritis among Native Hawaiians and Pacific Islanders, Whites, and Asians |
Q36299154 | Racial differences in B cell receptor signaling pathway activation |
Q35083469 | Rapid clinical progression to diagnosis among African-American men with systemic lupus erythematosus |
Q37629055 | Rates of autoimmune diseases in Kaiser Permanente for use in vaccine adverse event safety studies |
Q41582396 | Recognition and management of systemic lupus erythematosus |
Q35680662 | Report of an international symposium on narrowing the Gap in the treatment and study of SLE worldwide: minimum best practices in the management and monitoring of moderate to severe SLE and improving outcomes in constrained environments |
Q38076062 | Resource utilization and direct medical costs in adult systemic lupus erythematosus patients from a commercially insured population |
Q37640958 | Review: Male systemic lupus erythematosus: a review of sex disparities in this disease |
Q87359702 | SIRT1 promoter polymorphisms as clinical modifiers on systemic lupus erythematosus |
Q36369289 | Screening tests of reproductive immunology in systemic lupus erythematosus |
Q33408763 | Sex differences in patients with systemic lupus erythematosus from Northwest Spain. |
Q36453206 | Single-cell network profiling of peripheral blood mononuclear cells from healthy donors reveals age- and race-associated differences in immune signaling pathway activation |
Q51743751 | Skin disease is prevented but nephritis is accelerated by multiple pregnancies in autoimmune MRL/LPR mice. |
Q36790796 | Sm antibodies increase risk of death in systemic lupus erythematosus |
Q38798999 | Socioeconomic Status Contributes to Racial/Ethnic Disparities in Adverse Pregnancy Outcomes among Women with Systemic Lupus Erythematosus |
Q33738700 | Stress Intervention and Disease in African American Lupus Patients: The Balancing Lupus Experiences with Stress Strategies (BLESS) Study |
Q39801775 | Studies of Filipino patients with systemic lupus erythematosus: autoantibody profile of first-degree relatives |
Q26768534 | Systemic Lupus Erythematosus and Deficiencies of Early Components of the Complement Classical Pathway |
Q39201916 | Systemic Lupus Erythematosus and hearing disorders: Literature review and meta-analysis of clinical and temporal bone findings. |
Q37807147 | Systemic Lupus Erythematosus: Safe and Effective Management in Primary Care |
Q84420574 | Systemic lupus erythematosus |
Q37754835 | Systemic lupus erythematosus and ethnicity: nature versus nurture or nature and nurture? |
Q40440734 | Systemic lupus erythematosus and infections: a retrospective study in Saudis |
Q50961904 | Systemic lupus erythematosus in Malaysia: a study of 539 patients and comparison of prevalence and disease expression in different racial and gender groups. |
Q33357929 | Systemic lupus erythematosus in Tunisia. A multicentric study. About 295 cases |
Q46430510 | Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture |
Q88771422 | Systemic lupus erythematosus presenting with eye squinting: A rare association |
Q35597979 | Systemic lupus erythematosus. How to manage, when to refer |
Q35156161 | Systemic lupus erythematosus: from genes to organ damage |
Q35873057 | Systemic lupus erythematosus: lupus nephritis |
Q26741149 | Systemic lupus erythematosus: strategies to improve pregnancy outcomes |
Q36295937 | Taxonomy for systemic lupus erythematosus with onset before adulthood |
Q46458870 | The Incidence and Prevalence of Systemic Lupus Erythematosus in San Francisco County, California: The California Lupus Surveillance Project |
Q93190803 | The Predictive Value of Autoantibody Spectrum on Organ Damage in Patients With Systemic Lupus Erythematosus |
Q45021635 | The clinical manifestations and survival of systemic lupus erythematosus patients in Turkey: report from two centers |
Q38784456 | The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus. |
Q28649846 | The endothelial deprotection hypothesis for lupus pathogenesis: the dual role of C1q as a mediator of clearance and regulator of endothelial permeability |
Q34212462 | The epidemiology of autoimmune diseases |
Q35148597 | The epidemiology of systemic lupus erythematosus |
Q36198947 | The incidence and prevalence of systemic lupus erythematosus, 2002-2004: The Georgia Lupus Registry |
Q33374162 | The lowest surviving birth weight reported in a systemic lupus erythematosus patient: a review of the literature |
Q34574168 | The lupus band test in systemic lupus erythematosus patients. |
Q40188124 | The national incidence and clinical picture of SLE in children in Australia - a report from the Australian Paediatric Surveillance Unit |
Q40224772 | The prevalence of systemic autoimmune rheumatic diseases in Canadian pediatric populations: administrative database estimates |
Q24792607 | The role of X-chromosome inactivation in female predisposition to autoimmunity |
Q35119642 | The role of aspirin in women's health |
Q28389137 | The role of epigenetic mechanisms and processes in autoimmune disorders |
Q50263868 | The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies |
Q28188901 | Therapy insight: systemic lupus erythematosus as a risk factor for cardiovascular disease |
Q35927877 | Treatment of lupus nephritis with abatacept: the Abatacept and Cyclophosphamide Combination Efficacy and Safety Study |
Q44612340 | Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. |
Q33621131 | Understanding the epidemiology and progression of systemic lupus erythematosus |
Q49966482 | Understanding the role of environmental factors in the development of systemic lupus erythematosus |
Q36614958 | Unraveling the genetics of systemic lupus erythematosus |
Q57821296 | Update on Vertigo in Autoimmune Disorders, from Diagnosis to Treatment |
Q38011226 | Utilizing registries in systemic lupus erythematosus clinical research |
Q37137321 | Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohort |
Q64240142 | Whole-genome sequencing identifies complex contributions to genetic risk by variants in genes causing monogenic systemic lupus erythematosus |
Q93378945 | Yoga for systemic lupus erythematosus (SLE): Clinician experiences and qualitative perspectives from students and yoga instructors living with SLE |
Q47877230 | Young age of onset is associated with increased prevalence of circulating IgM rheumatoid factor and antinuclear antibodies at presentation in women with rheumatoid arthritis. |
Q84600107 | [Registrolesaf. Features of patients with systemic lupus erythematosus and antiphospholipid syndrome registered by rheumatologists and internists] |
Q50691910 | [Systemic lupus erythematosus in Martinique: an epidemiologic study]. |
Q84600757 | [Systemic lupus erythematosus. Infrequent clinical aspects] |
Search more.